Gleamer, a Paris, France-based manufacturer of AI-powered solutions for medical imaging, raised €27M in Series B funding.
The round, which brought the total amount to $36M, was led by Supernova Invest, and Heal Capital, with participation from XAnge, Elaia, Bpifrance via the funds Digital Venture and F3A from France 2030, MACSF, Crista Galli Ventures, and UI Investissement, as well as European radiologists.
The company intends to use the funds to expand its portfolio of solutions, strengthen its European and American teams, and accelerate its international development plans.
Led by Christian Allouche, CEO, Gleamer leverages AI to provide medical imaging solutions that support radiologists and clinicians in their diagnoses. The company has developed a comprehensive suite of AI-powered solutions for standard radiography including BoneView for detecting bone trauma lesions, ChestView for detecting pulmonary pathologies, BoneMeasurement for automating MSK measurements, and BoneAge for automating bone age estimation. All four solutions hold MDR class IIa CE certification in Europe. BoneView has also received FDA clearance for use in adults and children over the age of two. Now serving over 6,500 users in 650 institutions, spanning 24 countries, they process more than a million medical examinations each month.
FinSMEs
29/06/2023